BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9781650)

  • 1. LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast.
    Lininger RA; Park WS; Man YG; Pham T; MacGrogan G; Zhuang Z; Tavassoli FA
    Hum Pathol; 1998 Oct; 29(10):1113-8. PubMed ID: 9781650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary lesions of the breast: a molecular progression?
    Di Cristofano C; Mrad K; Zavaglia K; Bertacca G; Aretini P; Cipollini G; Bevilacqua G; Ben Romdhane K; Cavazzana A
    Breast Cancer Res Treat; 2005 Mar; 90(1):71-6. PubMed ID: 15770529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.
    Tsuda H; Fukutomi T; Hirohashi S
    Clin Cancer Res; 1995 Mar; 1(3):261-7. PubMed ID: 9815981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity on chromosome 16q suggests malignancy in core needle biopsy specimens of intraductal papillary breast lesions.
    Yoshida M; Tsuda H; Yamamoto S; Kinoshita T; Akashi-Tanaka S; Hojo T; Fukutomi T
    Virchows Arch; 2012 May; 460(5):497-504. PubMed ID: 22476400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast.
    Tsuda H; Takarabe T; Akashi-Tanaka S; Fukutomi T; Hirohashi S
    Mod Pathol; 2001 May; 14(5):382-8. PubMed ID: 11353046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different incidence of loss of heterozygosity on chromosome 16q between intraductal papilloma and intracystic papillary carcinoma of the breast.
    Tsuda H; Uei Y; Fukutomi T; Hirohashi S
    Jpn J Cancer Res; 1994 Oct; 85(10):992-6. PubMed ID: 7961109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity on chromosome 16p and 18q in anaplastic thyroid carcinoma.
    Kadota M; Tamaki Y; Sekimoto M; Fujiwara Y; Aritake N; Hasegawa S; Kobayashi T; Ikeda T; Horii A; Monden M
    Oncol Rep; 2003; 10(1):35-8. PubMed ID: 12469141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential diagnosis of intracystic papillary tumors of the breast by examination of loss of heterozygosity on chromosome 16q].
    Tsuda H
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():52-8. PubMed ID: 7747993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.
    Henske EP; Neumann HP; Scheithauer BW; Herbst EW; Short MP; Kwiatkowski DJ
    Genes Chromosomes Cancer; 1995 Aug; 13(4):295-8. PubMed ID: 7547639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a 7-cM region of frequent allelic loss on chromosome band 16p13.3 that is specifically associated with anaplastic thyroid carcinoma.
    Kadota M; Tamaki Y; Sakita I; Komoike Y; Miyazaki M; Ooka M; Masuda N; Fujiwara Y; Ohnishi T; Tomita N; Sekimoto M; Ohue M; Ikeda T; Kobayashi T; Horii A; Monden M
    Oncol Rep; 2000; 7(3):529-33. PubMed ID: 10767363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast.
    Troxell ML; Levine J; Beadling C; Warrick A; Dunlap J; Presnell A; Patterson J; Shukla A; Olson NR; Heinrich MC; Corless CL
    Mod Pathol; 2010 Jan; 23(1):27-37. PubMed ID: 19898424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
    Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
    Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
    J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: correlation with related protein products and morphologic features.
    Otis CN; Krebs PA; Albuquerque A; Quezado MM; San Juan X; Sobel ME; Merino MJ
    Int J Surg Pathol; 2002 Oct; 10(4):237-45. PubMed ID: 12490973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
    Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
    Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
    Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
    Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.